Healthy Volunteer Study | 3-Night In-Clinic Stay Novatrials is seeking healthy volunteers to join a paid clinical study of a potential new weight loss treatment. The purpose of this study …
CONDITION: Other
GENDER: Both males and females
AGE GROUP:?18?to 60 years
TRIAL STATUS:?Completed
Subcutaneous abdominal fat is the soft, pinchable layer located directly under the skin. High levels may be linked to health concerns like high blood pressure, elevated cholesterol, and elevated blood …
CONDITION: Other
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
The study is designed as a clinical feasibility, to investigate the positive and negative percent agreement (PPA and NPA) of the BinaxNOW™ COVID-19/Flu A&B Combo against a highly sensitive PCR …
CONDITION: Infection
GENDER: Both males and females
AGE GROUP:?2?and above
TRIAL STATUS:?Completed
Novatrials is seeking volunteers with gout to join a clinical study of a potential new treatment for gout flares. You may be eligible to join this trial if you: have …
CONDITION: Inflammatory and Immune System
GENDER: Both males and females
AGE GROUP:?18?to 70 years
TRIAL STATUS:?Completed
Novatrials is now running a clinical trial of a potential treatment aimed at alleviating the symptoms of PN. If you are currently diagnosed with PN, would like to help in …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP:?18?to 75 years
TRIAL STATUS:?Completed
A Phase 3, Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety and Immunogenicity of a SARS‑CoV‑2 rS Nanoparticle and Trivalent Hemagglutinin Nanoparticle Influenza Combination Vaccine with Matrix-M™ Adjuvant and a …
CONDITION: Other
GENDER: All
AGE GROUP:?60?and above
TRIAL STATUS:?Completed
A Phase 1a/1b, Blinded, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of Single- and Multiple-Ascending Doses of ABI-5366 in Healthy Subjects and in Subjects who are Seropositive for HSV-2 …
CONDITION: Other
GENDER: All
AGE GROUP:?18?to 60 years
TRIAL STATUS:?Completed
A Phase 1a/1b, Blinded, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of Single- and Multiple-Ascending Doses of ABI-5366 in Healthy Subjects and in Subjects who are Seropositive for HSV-2 …
CONDITION: Other
GENDER: All
AGE GROUP:?18?to 60 years
TRIAL STATUS:?Completed
CONDITION: Inflammatory and Immune System
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
A Randomized, Double-blind, Placebo-controlled, Parallel-group Multicenter Trial to Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects without Diabetes Mellitus
CONDITION: Metabolic and Endocrine
GENDER: All
AGE GROUP:?18?to 75 years
TRIAL STATUS:?Completed
CONDITION: Inflammatory and Immune System
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
A seven year plan of enhanced HCV monitoring, primary care–based workforce development, rapid scale-up of HCV treatment and public health policy action in HIV positive individuals within Australia.
CONDITION: Inflammatory and Immune System
GENDER: All
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
This is a phase III, randomized, multicenter, open-label study which will be performed to evaluate efficacy and safety of oral Gepotidacin compared to intramuscular (IM) ceftriaxone plus oral azithromycin for the treatment …
CONDITION: Infection
GENDER: All
AGE GROUP:?12?and above
TRIAL STATUS:?Completed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide …
CONDITION: Inflammatory and Immune System
GENDER: All
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
Patients presenting to the emergency department with acute ischemic stroke, who are are eligible for standard intravenous thrombolytic therapy within 4.5 hours of stroke onset will be assessed for major …
CONDITION: Stroke
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
ARE YOU AGED BETWEEN 50 and 80 YEARS OLD? ARE YOU FULLY VACCINATED AGAINST COVID-19 (with or without a booster)? You may qualify* to take part in a trial for …
CONDITION: Other
GENDER: Both males and females
AGE GROUP:?50?to 80 years
TRIAL STATUS:?Completed
Patients presenting to the emergency department with an acute ischemic stroke due to a large vessel occlusion eligible for thrombectomy and target mismatch on computed tomography perfusion imaging within 24 …
CONDITION: Stroke
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
One stick of sugar-free peppermint-flavoured chewing gum (Wrigley’s Extra Sugarfree Gum, Wrigley Company) in the event of nausea, retching and/or vomiting occurring in the post anaesthesia care unit (PACU) after …
CONDITION: Anaesthesiology
GENDER: Females
AGE GROUP:?12?and above
TRIAL STATUS:?Completed
VAPOR-C is a randomised study of the impact of IV versus inhaled anaesthesia (propofol versus sevoflurane) and lidocaine versus no lidocaine on duration of disease free survival inpatients with either …
CONDITION: Anaesthesiology
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
An Australian researcher is testing an investigational product (Hidracare). In this study, we are trying to find out if Hidracare solution, a salt mixture, could improve the skin condition Hidradentitis …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
Research Centre: NICM Health Research Institute, Western Sydney University Location: Online and via phone. No face to face contact is required with any member of the research team. Lead Doctor: …
CONDITION: Other
GENDER: Both males and females
AGE GROUP:?18?to 65 years
TRIAL STATUS:?Completed
Primary Objective: To determine the change in the following parameters following administration of RadianiX ™ Skin Melanin Index and Erythema Score Skin Hyperpigmentation Skin Elasticity Visual Skin Properties Skin Luminosity …
CONDITION: Skin
GENDER: Females
AGE GROUP:?30?to 65 years
TRIAL STATUS:?Completed
CheckMate-901 is a phase 3 open-label clinical research study of drugs named nivolumab and ipilimumab. This study will test these drugs in adults with cancer of the bladder or upper …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
Australian researchers are testing a new medication for idiopathic pulmonary fibrosis. This is a 60 day study with 10 separate visits. You will be treated at no cost, and most …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP:?40?to 80 years
TRIAL STATUS:?Completed
Footwear for self-managing knee osteoarthritis symptoms– volunteers needed! Researchers from the Centre for Health, Exercise and Sports Medicine at The University of Melbourne are conducting a research study to compare two …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP:?50?and above
TRIAL STATUS:?Completed
This project will specifically compare the effects of two different exercise programs for individuals with knee osteoarthritis who have higher body weights and evaluate if they respond differently to either …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP:?50?and above
TRIAL STATUS:?Completed
The use of NOX66 as a tumour cell-specific sensitiser of radiation therapy may provide greater response to targeted radiation therapy within the tumour cells, with the tumour specific nature of …
CONDITION: Cancer
GENDER: Males
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
An NHMRC funded clinical trial investigating the effects of a herbal medicine extract called Kava for individuals with Generalised Anxiety Disorder (GAD). The KGAD study is an 18-week, double blind, …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP:?18?to 70 years
TRIAL STATUS:?Completed
A 24-week, double blind placebo study investigating the effects of the amino acid ‘N-acetylcysteine’ (NAC) in Obsessive-Compulsive Disorder (OCD). This study will determine if NAC is an effective treatment for …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP:?18?to 75 years
TRIAL STATUS:?Completed
This trial is designed to evaluate the safety, tolerability, and preliminary efficacy of intra-tumour injections of SD-101 in combination with intravenous Keytruda (pembrolizumab) in patients with metastatic melanoma. Patients can have progressed …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP:?18?to 70 years
TRIAL STATUS:?Completed